These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9216837)

  • 21. Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.
    Hasegawa Y; Nishiyama Y; Imaizumi K; Ono N; Kinoshita T; Hatano S; Saito H; Shimokata K
    Cancer Gene Ther; 2000 Apr; 7(4):557-62. PubMed ID: 10811473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
    Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso JC
    Cancer Res; 1998 Dec; 58(24):5731-7. PubMed ID: 9865731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y; Gilbert JD; Kim JH; Freytag SO
    Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of cellular kinetics of reporter probe [(131)I]FIAU in neonatal cardiac myocytes after transfer of HSV1-tk reporter gene with two vectors.
    Lan X; Yin X; Wang R; Liu Y; Zhang Y
    Nucl Med Biol; 2009 Feb; 36(2):207-13. PubMed ID: 19217533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of the proliferation of herpes simplex virus type 1 thymidine kinase gene-transformed murine mammary FM3A carcinoma cells by (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    Balzarini J; De Clercq E; Ayusawa D; Shimizu K; Seno T
    Nucleic Acids Symp Ser; 1985; (16):283-6. PubMed ID: 3003708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive scintigraphic monitoring of gene expression in a HSV-1 thymidine kinase gene therapy model.
    Morin KW; Knaus EE; Wiebe LI
    Nucl Med Commun; 1997 Jul; 18(7):599-605. PubMed ID: 9342096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella-zoster virus thymidine kinase gene and antiherpetic pyrimidine nucleoside analogues in a combined gene/chemotherapy treatment for cancer.
    Degrève B; Andrei G; Izquierdo M; Piette J; Morin K; Knaus EE; Wiebe LI; Basrah I; Walker RT; De Clercq E; Balzarini J
    Gene Ther; 1997 Oct; 4(10):1107-14. PubMed ID: 9415318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-substituted-benzenes: "thymine replacement" analogs of thymidine for evaluation as anticancer and antiviral agents.
    Wang ZX; Duan W; Wiebe LI; Balzarini J; De Clercq E; Knaus EE
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(1-2):41-58. PubMed ID: 11303562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and ganciclovir analogues.
    Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
    Bioorg Med Chem; 2005 Mar; 13(6):2089-96. PubMed ID: 15727862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
    Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Delivery of "suicide" thymidine kinase gene of herpes virus in the complex with cationic peptide into human hepatoma cells in vitro].
    Ignatovich IA; Dizhe EB; Akif'ev BN; Burov SV; Boiarchuk EA; Perevozchikov AP
    Tsitologiia; 2002; 44(5):455-62. PubMed ID: 14696255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.
    Najjar AM; Nishii R; Maxwell DS; Volgin A; Mukhopadhyay U; Bornmann WG; Tong W; Alauddin M; Gelovani JG
    J Nucl Med; 2009 Mar; 50(3):409-16. PubMed ID: 19223410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect.
    Princen F; Robe P; Lechanteur C; Mesnil M; Rigo JM; Gielen J; Merville MP; Bours V
    Clin Cancer Res; 1999 Nov; 5(11):3639-44. PubMed ID: 10589781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.
    Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T
    Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J; Chen Y; Li H; Lu Y; Yan Y; Tan X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.